Results 81 to 90 of about 4,500 (120)

Role of Exogenous Phosphocreatine in Chemotherapy-Induced Cardiomyopathy

open access: yesReviews in Cardiovascular Medicine, 2017
The 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC) regimen is widely used in the management of breast cancer. The common cardiotoxic effects of doxorubicin include congestive heart failure and left ventricular dysfunction, and those of cyclophosphamide include pericarditis, myocarditis, and congestive heart failure. It has been postulated that
Swapnil Parve
exaly   +3 more sources
Some of the next articles are maybe not open access.

Related searches:

Oxidative Myocardial Damage: Protective Action of Exogenous Phosphocreatine

Bulletin of Experimental Biology and Medicine, 1990
Eugene A Konorev, V G Sharov, V A Saks
exaly   +2 more sources

Electrophysiologic Effects of Exogenous Phosphocreatine in Cardiac Tissue: Potential Antiarrhythmic Actions

American Heart Journal, 1990
The cellular electrophysiologic effects of exogenous phosphocreatine (PCr) were analyzed to ascertain its purported antiarrhythmic properties during myocardial ischemia and reperfusion. Transmembrane potentials were recorded from isolated guinea pig papillary muscles and Purkinje fibers studied in vitro.
L V Rosenshtraukh, George J Rozanski
exaly   +3 more sources

Participation of Calcium Ions in the Molecular Mechanism of Cardioprotective Action of Exogenous Phosphocreatine

Basic Research in Cardiology, 1991
The purpose of this study was to find out whether Ca2+ is necessary for the protective effect of phosphocreatine (PCr) on ischemic myocardium. Isolated Langendorff-perfused rat hearts were used in the study. When ischemic arrest was induced in Ca(2+)-free buffer, PCr did not exert a protective effect on ischemic myocardium.
V L Lakomkin, V A Saks
exaly   +3 more sources

Home - About - Disclaimer - Privacy